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Abstract
Background: Cells deploy quality control mechanisms to remove damaged or misfolded proteins. Recently, we have
reported that a mutation (R43W) in the Frank-ter Haar syndrome protein Tks4 resulted in aberrant intracellular localization.
Results: Here we demonstrate that the accumulation of Tks4R43W depends on the intact microtubule network.
Detergent-insoluble Tks4 mutant colocalizes with the centrosome and its aggregate is encaged by the intermediate
filament protein vimentin. Both the microtubule inhibitor nocodazole and the histone deacetylase inhibitor Trichostatin
A inhibit markedly the aggresome formation in cells expressing Tks4R43W. Finally, pretreatment of cells with the
proteasome inhibitor MG132 markedly increases the level of aggresomes formed by Tks4R43W. Furthermore, two
additional mutant Tks4 proteins (Tks41–48 or Tks41–341) have been investigated. Whereas the shorter Tks4 mutant,
Tks41–48, shows no expression at all, the longer Tks4 truncation mutant accumulates in the nuclei of the cells.
Conclusions: Our results suggest that misfolded Frank-ter Haar syndrome protein Tks4R43W is transported via the
microtubule system to the aggresomes. Lack of expression of Tks41–48 or aberrant intracellular expressions of Tks4R43W
and Tks41–341 strongly suggest that these mutations result in dysfunctional proteins which are not capable of operating
properly, leading to the development of FTHS.
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Background
Cells deploy quality control mechanisms to remove dam-
aged or misfolded proteins. These mechanisms include
up-regulated chaperones to facilitate protein refolding,
ubiquitin-dependent degradation of misfolded/damaged
proteins, and formation of detergent insoluble aggresomes
at the juxtanuclear region [1–4]. Aggresome formation is
a vital mechanism to eliminate misfolded proteins, never-
theless, it is not clear if it is an independent process or it
is activated only when the degradative capacity of the
ubiquitin-proteasome system is overwhelmed [5]. In this
system, misfolded and aggregated proteins are selectively
recognized, ubiquitinated, and delivered via HDAC6
(histone deacetylase 6)-dependent, microtubule-based trans-
port toward the microtubule-organizing center (MTOC) [6].
Aggresome formation not only protects cells from proteo-
toxicity but also facilitates the clearance of damaged proteins
by autophagy [6]. The accumulation of protein aggregates is
commonly linked with various human diseases referred to as
protein conformation disorders [7].
Frank-ter Haar syndrome (FTHS) is a rare disorder as-
sociated with cardiovascular, skeletal and craniofacial
anomalies including macrocornea with or without glau-
coma, brachycephaly, large anterior fontanels, hyperte-
lorism, anteverted nostrils, thoracolumbar kyphosis, and
short hands [8, 9]. Protruding simple ears and promin-
ent coccyx bone can be also regarded as important diag-
nostic signs [8, 9]. FTHS patients unfortunately die in
infancy or in early childhood due to cardiovascular
anomalies or respiratory infections. The most common
underlying genetic defect in FTHS has recently been
established through homozygosity mapping studies in
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patients, identifying homozygous mutations in the
SH3PXD2B gene on chromosome 5q35.1 [9]. The ana-
lysis of patients identified four different intragenic muta-
tions, and one complete deletion of SH3PXD2B [9]. A
novel mutation in FTHS patients has also been de-
scribed caused by the deletion of exon 13 of the
SH3PXD2B gene [10]. Recently, two new homozygous
loss-of-function mutations have been identified in the
SH3PXD2B gene in patients with Borrone dermato-
cardio-skeletal syndrome (BDSC syndrome) which is re-
lated to the FTHS [11]. SH3PXD2B null mice appear to
share many of the skeletal, craniofacial, cardiac and ocu-
lar defects described in FTHS, supporting the link be-
tween this gene and the syndrome [9]. Interestingly,
studying the spontaneous mouse mutant nee has re-
vealed that those mice also exhibited runted growth, cra-
niofacial and skeletal abnormalities, ocular anterior
segment dysgenesis, and hearing impairment, similar to
SH3PXD2B null mice [12]. Using genetic mapping and
DNA sequencing, the cause of nee phenotypes was iden-
tified as a 1 bp deletion within the SH3PXD2B gene on
mouse Chromosome 11 which causes a frameshift and a
protein truncation altering a portion of the third SH3
domain and deleting all of the fourth SH3 domain [12].
The protein product of the SH3PXD2B gene is known
as Tks4/HOFI/SH3PXD2B/fad49 (tyrosine kinase sub-
strate with four SH3 domains/homolog of FISH/SH3
and PX domain-containing protein 2B/factor for adipo-
cyte differentiation 49, hereafter termed Tks4). Tks4 has
emerged as a candidate scaffold molecule that has the
capability to regulate the actin cytoskeleton via Src and
EGFR [13–15]. In addition, Tks4 was shown to play an
important role in the formation of functional podosomes
[16], production of reactive oxygen species (ROS) by
tumor cells [17–19], and in the differentiation of white
adipose tissue [20]. In 2010, Iqbal and colleagues have
identified a family with FTHS whose SH3PXD2B gene
contains a substitution mutation which results in the
change of the conserved arginine 43 to tryptophan in
the PX domain [9]. We have recently demonstrated that
the R43W mutation seriously impairs the cellular ex-
pression and the function of Tks4 [14].
In the present study we further characterized the mu-
tant Tks4R43W protein in COS7 cells. Here we show that
mutant Tks4 is very likely misfolded since it is seen in
the detergent-insoluble fraction of cell extracts. In
addition, in some cells Tks4R43W colocalizes with micro-
tubules and the perinuclear Tks4 aggregate formation
depends on the intact microtubule network. The mis-
folded Tks4 mutant also colocalizes with the MTOC
and its aggregate is encaged by the intermediate filament
protein vimentin. Finally, pretreatment of cells with the
proteasome inhibitor MG132 markedly increases the
levels of aggresomes formed by Tks4R43W. Our results
therefore suggest that the misfolded FTHS protein
Tks4R43W is transported via the microtubular system to
aggresomes localized at the juxtanuclear region.
Results
Tks4R43W displays characteristics of misfolding
In 2010, Iqbal and colleagues have identified a patient
with FTHS whose SH3PXD2B gene contains a substitu-
tion mutation which results in the change of the con-
served arginine 43 to tryptophan in the PX domain.
Interestingly, the symptoms of this particular patient
were indistinguishable of those who had more severe
mutations leading to complete loss of Tks4 protein syn-
thesis [9]. This finding suggests that the Tks4R43W pro-
tein is likely damaged or misfolded, leading to reduced
intracellular protein concentration. We have previously
expressed Tks4R43W in COS7 cells and found that the
expression of the mutant protein was significantly de-
creased in cell lysates, it formed aggregates and accumu-
lated around the nucleus [14]. In this study Tks4R43W
protein was further characterized concerning its intracel-
lular behavior. Damaged or misfolded proteins in aggre-
somes are often insoluble in non-denaturing detergents
[4]. Therefore, we investigated the solubility of V5-
tagged mutant Tks4 by sequential extraction into
detergent-soluble and insoluble fractions. As shown in
Fig. 1, wild type Tks4 was found predominantly in the
detergent soluble fraction. However, Tks4R43W was sedi-
mented almost exclusively in the detergent-insoluble
pellet fraction. To exclude experimental artifact, the
solubility of a well-characterized cytosolic protein was
also determined. The E3 ubiquitin-protein ligase Cbl
was detected completely in the soluble fractions (Fig. 1,
[21, 22]). In addition, a marker of the pellet fraction
(caveolin) and an aggresome marker (HDAC6) were also
tested.
Different localization patterns of Tks4R43W protein in
COS7 cells
We have recently demonstrated that the R43W mutant
Tks4 aggregates in cells and the aggregate localizes at
the juxtanuclear region [14]. However, only a part of
Tks4R43W-expressing cells showed this localization pat-
tern. Therefore, we transiently expressed the V5-tagged
mutant Tks4 in cells, stained them with anti-V5 anti-
body, and categorized them based on the localization
patterns of Tks4R43W. We can distinguish the following
localization patterns: a, cells with uniform cytoplasmic
distribution (Fig. 2a/e), b, cells with aggresomes (Fig. 2a/f ),
c, cells with filamentous staining (Fig. 2a/g), finally,
d, cells with aggresomes and filamentous anti-V5 staining
together (Fig. 2a/h). To calculate the percentage of cells
showing different Tks4R43W localization, cells with V5-Tks4
immunreactivity were scrutinized under laser confocal
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microscope. We found that approximately 35 % of cells
showed uniform cytoplasmic distribution, while the per-
centage of cells containing aggressomes was around 32 %.
The percentage of cells with filamentous staining only or
with aggresomes was significantly lower, approximately
18 and 15 %, respectively (Fig. 2b). Taken together, it
seems that approximately half of the cells expressing
Tks4R43W contain aggresomes. To ensure that we can de-
tect Tks4R43W in the aggresomes, HDAC6, a marker of
aggresomes, was also stained (Fig. 2c).
The microtubule network delivers Tks4 R43W to aggresomes
Damaged or misfolded proteins are delivered via an
HDAC6-dependent, microtubule-based retrograde trans-
port toward the microtubule-organizing center (MTOC)
into aggresomes [6]. Using anti-alfa-tubulin fluorescent
staining we have shown that, in those cells where the
mutant Tks4 shows filamentous staining, Tks4R43W par-
tially colocalizes with the microtubule network, while
the wild type protein shows a uniform cytoplasmic dis-
tribution (Fig. 3).
In order to show that the transport of Tks4R43W is in-
deed microtubule dependent, we pretreated COS7 cells
with 1.6 μM of the microtubule depolymerizing drug
nocodazole for 16 h, which leads to destabilization of
the microtubule network (Fig. 4a). In the presence of
nocodazole, aggresome formation in Tks4R43W-express-
ing cells was largely inhibited (Fig. 4a/j-l, 4b). Interest-
ingly, in those cells protein aggregates of the mutant
Tks4 showed punctate structures throughout the cell,
Fig. 1 The Tks4R43W mutant protein is present in detergent-insoluble pellets. 1a, COS7 cells were transiently transfected with wild type V5-Tks4 or
V5-Tks4R43W constructs. After 18 h the cells were lysed, and the lysates were separated into detergent-soluble (S) and insoluble pellet fractions (P)
by centrifugation and analyzed by Western blotting for Tks4 (with anti-V5 antibody), Cbl, caveolin-1 and HDAC6, respectively. 1b, Wild type and
mutant Tks4 protein levels were determined by densitometry. Error bars represent the standard deviation from three independent experiments.
Asterisks indicate the level of significance (one asterisk, P < 0.05; two asterisks, P < 0.01; three asterisks, P < 0.001)
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Fig. 2 Different localization patterns of Tks4 and Tks4R43W proteins in cells. 2a, COS7 cells were transiently transfected with V5-Tks4, V5-Tks4R43W
or V5-empty constructs. After 18 h, cells were fixed and stained for Tks4 with anti-V5 antibody. 2b, The percentage of aggresomes in cells was
quantified by counting 300 cells/sample by using ImageJ software. Error bars represent the standard deviation from three independent experiments.
2c, Tks4R43W aggresomes colocalize with the HDAC6 aggresome marker. COS7 cells were transiently transfected with V5-Tks4 or V5-Tks4R43W constructs.
After 18 h, cells were fixed and stained stained for Tks4 (with anti-V5 antibody, red) and HDAC6 (green)
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Fig. 3 The Tks4R43W mutant protein colocalizes with the microtubule network of the cytoskeleton. COS7 cells were transiently transfected with wild type
V5-Tks4 (3g, h, i), V5-Tks4R43W (3j, k, l) or V5-empty (3d, e, f) constructs. Non-transfected cells are also shown (3a, b,c). After 18 h, cells were fixed and stained
for Tks4 (with anti-V5 antibody, red, 3b, e, j, k) and α-tubulin (green, 3a, d, g, j). Merged pictures are also shown (3c, f, i, l). Cell nuclei were visualized by DAPI
staining. The scale bar represents 10 μm
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reflecting that without active microtubule network small
aggregates of Tks4R43W cannot be delivered to the
MTOC and assembled to large cytoplasmic inclusions.
To prove the role of microtubules in the transport of
Tks4R43W in another way, cells expressing Tks4R43W
were treated with the histone deacetylase inhibitor Tri-
chostatin A (TSA). TSA is a well-known inhibitor of
HDAC6 that yields hyper-acetylated tubulin. It was found
that hyper-acetylated microtubules observed after TSA
treatment exhibited delayed depolymerization [23–25].
Figure 4c and Fig. 4d demonstrate that inhibition of
HDAC6 in Tks4R43W–expressing cells prevented aggresome
formation. Interestingly, misfolded Tks4 protein shows very
similar staining in these cells as seen in cells treated with
the microtubule depolymerizing drug nocodazole.
The aggresome formed by Tks4R43W colocalizes with the
centrosome
As described above, aggresomes are typically formed at
the MTOC at the juxtanuclear region. MTOC or centro-
some contains several specific proteins responsible for
microtubule nucleation and anchoring, including γ-
Fig. 4 Perinuclear Tks4R43W aggregate formation is microtubule and HDAC6-dependent. 4a, COS7 cells were transiently transfected with wild type
V5-Tks4 or V5-Tks4R43W constructs. After 4 h, the cells were treated with 1,6 μM nocodazole for 16 h. The cells were fixed and stained for Tks4
(with anti-V5 antibody, red) and α-tubulin (green). 4b, The percentage of aggresomes and punctate structures in cells was quantified by counting
300 cells/sample by using ImageJ software. 4c, COS7 cells were transiently transfected with wild type V5-Tks4 or V5-Tks4R43W constructs. After 4 h,
the cells were treated with 1 μM Trichostatin A (TSA) for 16 h. The cells were fixed and stained for Tks4 (with anti-V5 antibody, red) and α-tubulin
(green). 4d, The percentage of aggresomes and punctate structures in cells was quantified by counting 300 cells/sample by using ImageJ software.
Error bars represent the standard deviation from three independent experiments. Asterisks indicate the level of significance (one asterisk, P < 0.05;
two asterisks, P < 0.01; three asterisks, P < 0.001)
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tubulin, pericentrin, ninein and centrins [26]. To prove
that Tks4R43W aggregates are accumulated at the
MTOC, the centrosome marker protein centrin2 was
fused to GFP and was co-expressed with the wild type
Tks4 or Tks4R43W in COS7 cells. As demonstrated in
Fig. 5, aggresome formed by mutant Tks4 showed clear
colocalization with centrosome marker protein centrin2.
The Tks4R43W aggresome is encaged by vimentin
One of the most characteristic features of aggresomes is
the localization of the intermediate filament protein
vimentin which changes its normal fibrillar distribution
to form a cage surrounding the aggregates [3, 4]. To fur-
ther verify that the observed pericentriolar Tks4R43W ag-
gregate corresponds to aggresomes, subcellular localization
of vimentin was examined in cell expressing wild type and
mutant Tks4. In cells expressing wild type Tks4, vimentin
distribution was filamentous and dispersed throughout the
cell (Fig. 6a and c). However, in cells transfected with
TKS4R43W vimentin filaments were seen to form a ring-
like structure around the aggregated proteins in the juxta-
nuclear region (Fig. 6d and f).
The proteasome inhibitor MG132 increases the level of
aggresome formation by Tks4R43W
In our previous experiments we have shown that
Tks4R43W is transported to the centrosome where it can
be sequestered in aggresomes. Nevertheless, other mech-
anisms, such as proteasomal degradation may also con-
tribute to the clearance of this misfolded protein. To test
if the proteasomal system significantly contributes to the
elimination of Tks4R43W, we challenged the cells with
the cell-permeable proteasome inhibitor MG132. Figure 7a
and b show that pretreatment of the cells with 5 μM
MG132 for 20 h significantly increased the percentage of
cells with perinuclear aggregates. To see the effect of
MG132 on protein levels too, cells treated with the inhibi-
tor were separated into detergent soluble and insoluble
fractions, as performed in Fig. 1. Figure 7c and d demon-
strates that the protein levels present in the pellet fractions
of MG132-treated cells were significantly increased in
cells expressing the mutant Tks4 proteins. These findings
suggest that the ubiquitin-proteasome system also con-
tributes to the elimination of the mutant Tks4 proteins.
Other mutations of the FTHS patients also result in
aberrant expression of Tks4 proteins
In addition to the R43W mutation, Iqbal et al. described
two further mutations in the SH3PXD2B gene of FTHS
patients. A homozygous insertion c.147insT was de-
tected which predicted the creation of an immediate
stop in the same codon resulting a 48 amino acid long
protein (Tks41–48). In other patients, a homozygous
1 bp deletion c.969delG was identified which predicted
a frameshift followed by a premature stop codon
(p.G323fsX19). The expected protein possesses 341
amino acids (Tks41–341) and the truncation occurs after
the second SH3 domain in the structure of Tks4 [9].
To check the expression and the intracellular
localization of these mutants, cDNA constructs were
Fig. 5 Aggresomes formed by Tks4R43W mutant colocalizes with the centrosome. COS7 cells were transiently transfected with hCent2-pEGFP-C1 and V5-Tks4
(5a, b, c) or hCent2-pEGFP-C1 and V5-Tks4R43W (5d, e, f) constructs. After 18 h, cells were fixed and stained for Tks4 with anti-V5 antibody (red). Cell nuclei
were visualized by DAPI staining. The arrow indicates the localization of centrin2 present at the juxtanuclear region. The scale bar represents 10 μm
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generated as described in the Methods. V5- Tks41–48
and V5- Tks41–341 were transiently expressed in COS7
cells, protein lysates were then subjected to SDS-PAGE
and immunoblot with an anti-V5 monoclonal antibody.
As demonstrated in Fig. 8a, wild type Tks4 and
Tks4R43W can be detected with an apparent molecular
weight of 140 kDa. It is worth to note that due to the
over-expression of the proteins some degradation can
be seen at lower molecular weights. Interestingly, the
shorter Tks4 mutant, Tks41–48, shows no expression at
all. Finally, expression of the Tks41–341 can be detected
with an approximate molecular weight of 45 kDa. Next,
we transiently expressed the V5-tagged Tks4 proteins
in cells. As Fig. 8b demonstrates, a portion of Tks4R43W
localizes at the juxtanuclear region in the aggresome, as
described above (Fig. 2a). Tks41–48, as expected, did not
express in the cell. Finally, Tks41–341 shows an interest-
ing picture accumulating in the nuclei of the cells.
Taken together, while Tks41–48 shows no expression in the
cells, the other two mutants, Tks4R43W and Tks41–341,
show abnormal intracellular localizations.
Discussion
FTHS is an autosomal-recessive disorder characterized by
abnormalities that affect bone, heart, and eye develop-
ment. Patients usually die in infancy or in early childhood
because of the cardiovascular anomalies, respiratory infec-
tions or unknown causes [9]. Iqbal and colleagues have in-
vestigated several families with FTHS and revealed five
different homozygous mutations in the SH3PXD2B gene
encoding for Tks4 [9]. One particularly interesting muta-
tion of them is the change of the highly conserved argin-
ine 43 to tryptophan within the PX domain of Tks4 [9].
We have recently demonstrated that the R43W mutation
seriously impairs the lipid-binding of the PX domain and
the cellular expression of Tks4 [14].
In the present study we have further characterized the
mutant Tks4R43W protein and studied the mechanism by
which the misfolded Tks4 is sequestered. We prove here
that the Tks4R43W protein is transported via the micro-
tubule network to aggresomes. This is based on the fol-
lowing findings: a, Tks4R43W shows partial colocalization
with the microtubule network; b, both nocodazole, a
microtubule-depolymerizing drug, and Trichostatin A, a
histone deacetylase inhibitor, inhibit aggresome forma-
tion in cells expressing the mutant Tks4; c, Tks4R43W
shows colocalization with the centrosome-specific cen-
trin2; d, finally, the intermediate filament protein vimen-
tin forms a ring-like structure around the Tks4R43W
aggregates.
Much evidence has accumulated to indicate that the
aggresome represents a special protective response to
proteotoxic stresses [1, 2, 4, 27]. However, it is not clear
if aggresome formation is an independent process or it
is activated only when the degradative capacity of the
ubiquitin-proteasome system is overwhelmed. Our data
based on the characteristics of the Tks4R43W favor the
second alternative. Pretreatment of cells with the cell-
permeable proteasome inhibitor MG132 resulted in the
dramatic increase in the number of Tks4R43W expressing
Fig. 6 Tks4R43W aggresome is encaged by vimentin. COS7 cells were transiently transfected with wild type V5-Tks4 (6a, b, c) or V5-Tks4R43W (6d, e, f)
constructs. After 18 h, cells were fixed and stained for Tks4 (with anti-V5 antibody, red) and vimentin (green). Cell nuclei were visualized by DAPI
staining. The scale bar represents 10 μm
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cells with perinuclear aggregates. Therefore, it is likely that
mutant Tks4 is also eliminated by the ubiquitin-
proteasome system. However, immunoblotting of the
immunopericipated Tks4R43W with specific anti-ubiquitin
antibody did not detect the ubiquitination of the mutant
Tks4 (data not shown). Further experiment will therefore
be required to establish the precise mechanism by which
the proteasome system eliminates the misfolded Tks4.
Finally, we have constructed two other mutant Tks4
proteins which were predicted earlier by studying FTHS
patients [9]. We wished to investigate how they express
in cells and what their intracellular localization is. The
V5-tagged, 48 amino acid long protein (Tks41–48)
showed no expression at all in cells studied either by im-
munoblot or by confocal microscopy. However, when
the V5-tagged, 341 amino acid long truncation mutant
(Tks41–341) were transiently expressed in COS7 cell, and
cell lysates were prepared and subjected to anti-V5 im-
munoblot, a specific band was detected with an
approximate molecular weight of 45 kDa. Interestingly,
Tks41–341 was localized primarily in the nuclei of the
cells. The expression levels of the shorter truncation
mutant Tks4 (c.147insT, Tks41–48) were analyzed earlier
by immunoblot of total cell lysates of human primary
dermal fibroblasts isolated from FTHS patient. While
Tks4 signal was detected in control fibroblasts, no signal
was seen in cells of FTHS patients [9]. Our finding using
transiently over-expressed cell system is in agreement
with the above finding, namely that we could also not
detected the expression of Tks41–48 protein in cells.
Interestingly, Iqbal et al. detected normal levels of
SH3PXD2B transcript in FTHS families with the
c.147insT (F49X) mutation, excluding that the prema-
ture stop codon introduced by this mutation results in
nonsense-mediated RNA decay. They guessed that the
truncation resulted in an unstable protein [9]. Taken to-
gether, lack of expression of Tks41–48 or aberrant intra-
cellular expressions of Tks4R43W and Tks41–341 strongly
Fig. 7 The proteasome inhibitor MG132 increases the level of aggresome formation by the Tks4R43W mutant. 7a, COS7 cells were transiently
transfected with a V5-Tks4 and V5-Tks4R43W construct. After 18 h, the cells were treated with 5 μM MG132 for 20 h. The cells were fixed and
stained for Tks4 (with anti-V5 antibody, red) and α-tubulin (green). Cell nuclei were visualized by DAPI staining. 7b, The percentage of cells with
aggresomes was quantified by counting 300 cells/sample by using the ImageJ software. 7c, COS7 cells were transiently transfected with V5-Tks4
and V5-Tks4R43W construct. After 18 h the cells were treated with 5 μM MG132 for 20 h or left untreated. Cells were then lysed, and the lysates
were separated into detergent-soluble (S) and insoluble pellet fractions (P) by centrifugation and analyzed by Western blotting for Tks4 (with
anti-V5 antibody), Cbl, caveolin-1 and HDAC6, respectively. 7d, The Tks4 protein levels were determined by densitometry. Error bars represent the
standard deviation from three independent experiments. Asterisks indicate the level of significance (one asterisk, P < 0.05; two asterisks, P < 0.01;
three asterisks, P < 0.001)
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Fig. 8 The expression patterns of Tks4 mutant proteins. 8a, COS7 cells were transiently transfected with V5-Tks4, V5-Tks4R43W, V5-Tks41–48 and
V5-Tks41–341 constructs. After 18 h the cells were lysed, the lysates were separated by centrifugation and the supernatant analyzed by Western
blotting for Tks4 with anti-V5 antibody. 8b, COS7 cells were transiently transfected with V5-Tks4, V5-Tks4R43W, V5-Tks41–48 and V5-Tks41–341 constructs.
After 18 h, cells were fixed and stained for Tks4 (with anti-V5 antibody, red) and α-tubulin (green). Cell nuclei were visualized by DAPI staining. The scale
bar represents 10 μm
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suggest that these mutations result in dysfunctional pro-
teins which are not capable of operating properly, lead-
ing to the development of FTHS.
It has been well established that both Tks4 and Tks5
play important roles in the regulation and formation of
podosomes [16, 28, 29]. Podosomes represent transient
subcellular structures that are actin-rich membrane pro-
trusions found on the ventral surface of the cells facing
the extracellular matrix. The migration of normal cells is
driven by podosomes when these specialized structures
allow the cells to adhere and invade in the surroundings
[29]. Since podosomes are necessary for the adhesion
and migration of a variety of cell types, including macro-
phages, dendritic cells, osteoclasts, vascular smooth
muscle, and endothelial cells [9], it is likely that dysfunc-
tional Tks4 proteins are implicated in the development
of FTHS phenotype.
Conclusions
In summary, we show that the mutant FTHS protein
Tks4R43W is found in the detergent-insoluble cell fractions.
The misfolded protein seems to be transported to the
aggresomes via the microtubule system. Lack of expression
of Tks41–48 or aberrant intracellular expressions of
Tks4R43W and Tks41–341 strongly suggest that these muta-
tions result in dysfunctional proteins which are not capable
of operating properly, leading to the development of FTHS.
Methods
Antibodies, constructs and reagents
Monoclonal and polyclonal antibodies against the V5
epitope (R96025 and AB3792) were purchased from
Invitrogen (Carlsbad, CA, USA) and Millipore (Billerica,
MA, USA), respectively. Antibody against α-tubulin
(DM1A) and vimentin (V6630) were obtained from
Sigma-Aldrich (St. Louis, MO, USA). Antibody against
Cbl (sc-170) was from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA, USA). Antibody against HDAC6
(7558) and caveolin-1 (3267) were obtained from Cell
Signaling Technology (Danvers, MA, USA). The anti-
rabbit and anti-mouse HRP-linked antibodies (NA934V,
NA931V) were purchased from GE Healthcare (Little
Chalfont, Buckinghamshire, United Kingdom). Alexa
Fluor 488 anti-rabbit (A11034), Alexa Fluor 488 anti-
mouse (A11029), Alexa Fluor 546 anti-rabbit (A11035),
and Alexa Fluor 546 anti-mouse (A11030) antibodies
were purchased from Invitrogen (Carlsbad, CA, USA).
The generation of V5 epitope tagged Tks4 and the V5-
Tks4R43W mutant was described previously [13, 14]. To
generate the V5-tagged Tks41–48 and Tks41–341 proteins
[9], the shorter Tks4 coding sequences was amplified by
PCR and subcloned into BamHI/XbaI sites of
pcDNA3.1/TOPO-V5-His plasmid (Life Technologies,
Carlsbad, CA, USA). The single guanine change was
introduced into the c.969delG deletion mutant-V5 con-
struct (V5- Tks41–341) using the QuikChange Lightning
Site-Directed Mutagenesis Kit (Agilent Technologies).
The constructs were verified by sequencing. The human
centrin2 containing hCent2-pEGFP-C1 construct was a
kind gift of Jeffrey L. Salisbury (Tulane University, USA).
Stock solutions of MG132 (474790, Calbiochem), noco-
dazole (M1404, Sigma-Aldrich) and Trichostatin A
(T8552, Sigma-Aldrich) were prepared according to the
manufacturer’s instructions. Pfu DNA polymerase (EP0501)
was purchased from Thermo Scientific (Waltham, MA,
USA). The BamHI (1010A) and XbaI (1093A) enzymes
were purchased from Takara Bio Inc (Otsu, Shiga, Japan).
Cell lines, transfection, and inhibition
COS7 cells were purchased from American Type Culture
Collection and maintained in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10 % fetal calf serum
(Invitrogen, Carlsbad, CA, USA), penicillin (100 units/ml),
and streptomycin (100 μg/ml). All cell lines were transi-
ently transfected with Lipofectamine (Invitrogen) accord-
ing to the manufacturer’s instructions. In the experiments
where indicated, transfected cells were pretreated with
5 μM MG132 for 20 h, 1.6 μM nocodazole for 16 h or
1 μM Trichostatin A for 16 h after the transfection.
Confocal microscopy
COS7 cells plated on glass cover slips were transiently
transfected with different constructs as indicated and
then incubated for 4 or 18 h. When indicated 5 μM
MG132 were added 18 h after transfection for 20 h. In
other experiments cells were treated with 1.6 μM noco-
dazole or with 1 μM Trichostatin A for 16 h starting 4 h
after transfection. The cells were fixed in 4 %
paraformaldehyde-PBS for 15 min or in −20 °C metha-
nol for 5 min (in centrosome colocalization experiment),
permeabilized in 0.2 % Triton X-100 in PBS for 5 min,
and blocked with 1 % BSA in PBS for 20 min. Anti-V5
polyclonal rabbit and anti-α-tubulin antibody was ap-
plied in 1:1000 dilution for 30 min. After washing with
PBS the samples were incubated with Alexa Fluor 488
(or 546) labeled anti-mouse or anti-rabbit secondary
antibody for 30 min in 1:1000 dilution. After 30 min of
washing with PBS cover slips were mounted onto slides
in a 100 mM Tris–HCl buffer, pH 8.5, containing 10 %
Mowiol 4–88 (Calbiochem), 25 % glycerol, and 2.5 %
1,4-diazobicyclo- [2.2.2]octane (DABCO, Sigma-Aldrich,
St. Louis, MO, USA). The pictures of fixed samples were
acquired on a Zeiss LSM710 inverted confocal micro-
scope with 63X objective (Carl Zeiss, Jena, Germany).
To minimize the cross-talk between imaged channels,
sequential image collection was used. Cells are shown as
single confocal section. All images were processed using
ZEN software (Carl Zeiss, Jena, Germany).
Ádám et al. Cell Communication and Signaling  (2015) 13:33 Page 11 of 13
Characterization of aggregates and western blotting
The sequential extraction of aggregates was performed
according to [30]. Equal volumes of protein extracts
from each fraction (supernatant, pellet) were subjected
to SDS-PAGE and transferred to nitrocellulose mem-
branes (Bio-Rad, Hercules, CA, USA). Membranes were
then blocked with 5 % skim milk powder, incubated with
monoclonal anti-V5, Cbl, caveolin-1 or HDAC6 primary
antibodies, and horseradish peroxidase-conjugated sec-
ondary antibodies, and developed using ECL detection
reagents (GE Healthcare, Little Chalfont, Buckingham-
shire, United Kingdom). Densitometry on scanned
images was done using the ImageJ 1.46x software.
Statistics
The number of aggresomes was quantified by counting
300 cells/sample by using ImageJ software. Quantitative
results are presented as mean and s.d. of at least three
independent experiments. Statistical differences between
two groups of data were analyzed by Student’s t-test.
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